MAP4K Family Kinases in Immunity and Inflammation
- PMID: 26791862
- DOI: 10.1016/bs.ai.2015.09.006
MAP4K Family Kinases in Immunity and Inflammation
Abstract
MAP kinase kinase kinase kinases (MAP4Ks) belong to the mammalian Ste20-like family of serine/threonine kinases. MAP4Ks including MAP4K1/HPK1, MAP4K2/GCK, MAP4K3/GLK, MAP4K4/HGK, MAP4K5/KHS, and MAP4K6/MINK have been reported to induce JNK activation through activating the MAP3K-MAP2K cascade. The physiological roles of MAP4Ks in immunity and inflammation are largely unknown until recent studies using biochemical approaches and knockout mice. Surprisingly, JNK is not the major target of MAP4Ks in immune cells; MAP4Ks regulate immune responses through novel targets. HPK1 inhibits T-cell receptor (TCR) signaling and B-cell receptor signaling via inducing phosphorylation/ubiquitination of SLP-76 and BLNK, respectively. GLK activates TCR signaling through phosphorylating/activating PKCθ. T-cell-mediated immune responses and Th17-mediated experimental autoimmune diseases are enhanced in HPK1 knockout mice but ameliorated in GLK knockout mice. Consistently, HPK1 levels are decreased in peripheral blood mononuclear cells and T cells from patients with psoriatic arthritis and systemic lupus erythematosus (SLE), respectively. Moreover, GLK levels are increased in T cells from patients with SLE, rheumatoid arthritis, or adult-onset Still's disease; the percentages of GLK-overexpression T cells are correlated with the disease activity. In addition, HGK phosphorylates and induces TRAF2 protein degradation, leading to negative regulation of IL-6 production in resting T cells. Loss of HGK in T cells results in spontaneous systemic inflammation and type 2 diabetes in mice. HGK is also involved in cancer cell migration. To date, the phenotypes of knockout mice for GCK, KHS, and MINK have not been reported; the roles of these three MAP4Ks in immune cell signaling are discussed in this review. Taken together, MAP4K family kinases play diverse roles in immune cell signaling, immune responses, and inflammation.
Keywords: GCK; GLK; HGK; HPK1; Immunity; Inflammation; KHS; MAP4K; MINK.
© 2016 Elsevier Inc. All rights reserved.
Similar articles
-
MAP4K3/GLK in autoimmune disease, cancer and aging.J Biomed Sci. 2019 Oct 22;26(1):82. doi: 10.1186/s12929-019-0570-5. J Biomed Sci. 2019. PMID: 31640697 Free PMC article. Review.
-
MAP4K Family Kinases and DUSP Family Phosphatases in T-Cell Signaling and Systemic Lupus Erythematosus.Cells. 2019 Nov 13;8(11):1433. doi: 10.3390/cells8111433. Cells. 2019. PMID: 31766293 Free PMC article. Review.
-
The kinase GLK controls autoimmunity and NF-κB signaling by activating the kinase PKC-θ in T cells.Nat Immunol. 2011 Oct 9;12(11):1113-8. doi: 10.1038/ni.2121. Nat Immunol. 2011. PMID: 21983831
-
Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.J Autoimmun. 2011 Nov;37(3):180-9. doi: 10.1016/j.jaut.2011.09.006. Epub 2011 Oct 19. J Autoimmun. 2011. PMID: 22014533
-
AhR-ROR-γt complex is a therapeutic target for MAP4K3/GLKhighIL-17Ahigh subpopulation of systemic lupus erythematosus.FASEB J. 2019 Oct;33(10):11469-11480. doi: 10.1096/fj.201900105RR. Epub 2019 Aug 1. FASEB J. 2019. PMID: 31318609 Free PMC article.
Cited by
-
A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.Int J Mol Sci. 2022 Sep 30;23(19):11588. doi: 10.3390/ijms231911588. Int J Mol Sci. 2022. PMID: 36232890 Free PMC article.
-
GLK/MAP4K3 overexpression associates with recurrence risk for non-small cell lung cancer.Oncotarget. 2016 Jul 5;7(27):41748-41757. doi: 10.18632/oncotarget.9410. Oncotarget. 2016. PMID: 27203390 Free PMC article.
-
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.Sci Rep. 2019 Sep 30;9(1):14020. doi: 10.1038/s41598-019-50160-w. Sci Rep. 2019. PMID: 31570734 Free PMC article.
-
Bioinformatics analyses on the immune status of renal transplant patients, a systemic research of renal transplantation.BMC Med Genomics. 2020 Feb 11;13(1):24. doi: 10.1186/s12920-020-0673-6. BMC Med Genomics. 2020. PMID: 32046717 Free PMC article.
-
LncRNA LINC01857 promotes cell growth and diminishes apoptosis via PI3K/mTOR pathway and EMT process by regulating miR-141-3p/MAP4K4 axis in diffuse large B-cell lymphoma.Cancer Gene Ther. 2021 Sep;28(9):1046-1057. doi: 10.1038/s41417-020-00267-4. Epub 2020 Dec 12. Cancer Gene Ther. 2021. PMID: 33311569
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous